The latest news about Lumendi
ASGE Webinar Online
PIONEERING ENDOSURGERY NEW MISSION STATEMENT AT LUMENDI
Pioneering Endosurgery reflects Lumendi’s innovative, three-part pathway to:
expand indication areas and procedures in the upper gastrointestinal tract, which includes a recent submission to the FDA;
innovate improvements planned for the DiLumen EIP, including a proprietary lubricated inner surface of DiLumen’s sheath for better endoscope handling performance; and
commercially release the DiLumen C2 platform[1] to bring robotic-like end-effectors to endolumenal surgery in a low-cost, disposable format to provide endoscopists with unprecedented control of tissue.
LUMENDI REPORTS FIRST INCISIONLESS APPENDECTOMY USING DOUBLE-BALLOON ENDOLUMENAL INTERVENTIONAL PLATFORM
Dr. Kantsevoy states, “Endoscopic endolumenal appendectomy is less invasive than traditional surgical, laparoscopic, transvaginal or transgastric appendectomy.
Early Trial Data Show Promise in Endoscopic Procedure Time Study
A study evaluating endoscopic procedure time removing complex colorectal polyps shows superiority of Lumendi’s DiLumen device over a control group.
LUMENDI OPERATIONS AND CLINICAL SUPPORT REMAIN AVAILABLE DURING OBSERVANCE OF COVID-19 PRECAUTIONS.
We have adapted our operation and clinical support models as healthcare facilities prioritize focus on patients affected by COVID-19.
LUMENDI REPORTS SUCCESSFUL ENROLLMENT CLOSURE OF ITS DILUMEN™ ENDOLUMENAL INTERVENTIONAL PLATFORM (EIP™) STUDY
The study evaluates DiLumen’s effect on endoscopic procedure time for pre-cancerous colorectal complex polypectomies.
LARGE COMPLEX POLYPS REMOVED SUCCESSFULLY FROM THREE PATIENTS WITHOUT SURGICAL INTERVENTION USING LUMENDI DILUMEN C2™
The first successful case at Cleveland Clinic using DiLumen C2 was completed by Dr. Gorgun when a large complex polyp in the distal sigmoid, 18cm from the anus was removed from a 72-year-old woman with a narrow sigmoid.